RADNET INC (RDNT) Stock Fundamental Analysis
NASDAQ:RDNT - Nasdaq - US7504911022 - Common Stock - Currency: USD
We assign a fundamental rating of 4 out of 10 to RDNT. RDNT was compared to 103 industry peers in the Health Care Providers & Services industry. RDNT has only an average score on both its financial health and profitability. While showing a medium growth rate, RDNT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year RDNT was profitable.
RDNT had a positive operating cash flow in the past year.
Of the past 5 years RDNT 4 years were profitable.
In the past 5 years RDNT always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of -0.97%, RDNT perfoms like the industry average, outperforming 46.60% of the companies in the same industry.
RDNT has a Return On Equity of -3.60%. This is comparable to the rest of the industry: RDNT outperforms 48.54% of its industry peers.
RDNT has a Return On Invested Capital (2.38%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for RDNT is significantly below the industry average of 9.71%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.97% | ||
| ROE | -3.6% | ||
| ROIC | 2.38% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
1.3 Margins
RDNT's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 4.38%, RDNT perfoms like the industry average, outperforming 58.25% of the companies in the same industry.
In the last couple of years the Operating Margin of RDNT has remained more or less at the same level.
With a Gross Margin value of 22.61%, RDNT perfoms like the industry average, outperforming 46.60% of the companies in the same industry.
RDNT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.38% | ||
| PM (TTM) | N/A | ||
| GM | 22.61% |
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
2. Health
2.1 Basic Checks
RDNT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for RDNT remains at a similar level compared to 1 year ago.
Compared to 5 years ago, RDNT has more shares outstanding
RDNT has a worse debt/assets ratio than last year.
2.2 Solvency
RDNT has an Altman-Z score of 1.80. This is a bad value and indicates that RDNT is not financially healthy and even has some risk of bankruptcy.
RDNT has a Altman-Z score of 1.80. This is comparable to the rest of the industry: RDNT outperforms 42.72% of its industry peers.
RDNT has a debt to FCF ratio of 12.96. This is a negative value and a sign of low solvency as RDNT would need 12.96 years to pay back of all of its debts.
With a Debt to FCF ratio value of 12.96, RDNT perfoms like the industry average, outperforming 43.69% of the companies in the same industry.
RDNT has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
RDNT's Debt to Equity ratio of 1.10 is on the low side compared to the rest of the industry. RDNT is outperformed by 66.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.1 | ||
| Debt/FCF | 12.96 | ||
| Altman-Z | 1.8 |
ROIC/WACC0.27
WACC8.79%
2.3 Liquidity
A Current Ratio of 2.01 indicates that RDNT has no problem at all paying its short term obligations.
RDNT has a better Current ratio (2.01) than 73.79% of its industry peers.
A Quick Ratio of 2.01 indicates that RDNT has no problem at all paying its short term obligations.
RDNT has a Quick ratio of 2.01. This is in the better half of the industry: RDNT outperforms 76.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.01 | ||
| Quick Ratio | 2.01 |
3. Growth
3.1 Past
The earnings per share for RDNT have decreased strongly by -67.69% in the last year.
RDNT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.79% yearly.
Looking at the last year, RDNT shows a quite strong growth in Revenue. The Revenue has grown by 12.76% in the last year.
The Revenue has been growing by 9.65% on average over the past years. This is quite good.
EPS 1Y (TTM)-67.69%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%-600%
Revenue 1Y (TTM)12.76%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%9.19%
3.2 Future
Based on estimates for the next years, RDNT will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.09% on average per year.
Based on estimates for the next years, RDNT will show a quite strong growth in Revenue. The Revenue will grow by 8.17% on average per year.
EPS Next Y-62.53%
EPS Next 2Y8.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year7.99%
Revenue Next 2Y8.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 264.19, RDNT can be considered very expensive at the moment.
Based on the Price/Earnings ratio, RDNT is valued a bit more expensive than the industry average as 61.16% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 27.30. RDNT is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 75.37 indicates a quite expensive valuation of RDNT.
The rest of the industry has a similar Price/Forward Earnings ratio as RDNT.
RDNT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.76.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 264.19 | ||
| Fwd PE | 75.37 |
4.2 Price Multiples
RDNT's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of RDNT is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 53.42 | ||
| EV/EBITDA | 15.73 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)15.74
EPS Next 2Y8.09%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for RDNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
55.48
-2.02 (-3.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners93.09%
Inst Owner Change0%
Ins Owners13.48%
Ins Owner Change-0.4%
Market Cap4.16B
Analysts86.15
Price Target73 (31.58%)
Short Float %10.21%
Short Ratio9.75
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-77.8%
Min EPS beat(2)-161.6%
Max EPS beat(2)5.99%
EPS beat(4)2
Avg EPS beat(4)-35.08%
Min EPS beat(4)-161.6%
Max EPS beat(4)20.87%
EPS beat(8)6
Avg EPS beat(8)178.25%
EPS beat(12)7
Avg EPS beat(12)117.98%
EPS beat(16)9
Avg EPS beat(16)-190%
Revenue beat(2)2
Avg Revenue beat(2)2.78%
Min Revenue beat(2)1.29%
Max Revenue beat(2)4.27%
Revenue beat(4)4
Avg Revenue beat(4)2.9%
Min Revenue beat(4)1.29%
Max Revenue beat(4)4.27%
Revenue beat(8)8
Avg Revenue beat(8)1.8%
Revenue beat(12)10
Avg Revenue beat(12)1.98%
Revenue beat(16)12
Avg Revenue beat(16)0.96%
PT rev (1m)-0.6%
PT rev (3m)-4.99%
EPS NQ rev (1m)1.73%
EPS NQ rev (3m)-10.47%
EPS NY rev (1m)-27.53%
EPS NY rev (3m)-49.87%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)-0.18%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)1.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 264.19 | ||
| Fwd PE | 75.37 | ||
| P/S | 2.23 | ||
| P/FCF | 53.42 | ||
| P/OCF | 16.17 | ||
| P/B | 4.63 | ||
| P/tB | 41.25 | ||
| EV/EBITDA | 15.73 |
EPS(TTM)0.21
EY0.38%
EPS(NY)0.74
Fwd EY1.33%
FCF(TTM)1.04
FCFY1.87%
OCF(TTM)3.43
OCFY6.18%
SpS24.91
BVpS11.97
TBVpS1.35
PEG (NY)N/A
PEG (5Y)15.74
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.97% | ||
| ROE | -3.6% | ||
| ROCE | 2.9% | ||
| ROIC | 2.38% | ||
| ROICexc | 3.19% | ||
| ROICexgc | 5.13% | ||
| OM | 4.38% | ||
| PM (TTM) | N/A | ||
| GM | 22.61% | ||
| FCFM | 4.17% |
ROA(3y)0.21%
ROA(5y)0.2%
ROE(3y)1.34%
ROE(5y)1.17%
ROIC(3y)2.96%
ROIC(5y)2.94%
ROICexc(3y)3.61%
ROICexc(5y)3.42%
ROICexgc(3y)6.03%
ROICexgc(5y)5.63%
ROCE(3y)3.6%
ROCE(5y)3.56%
ROICexcg growth 3Y-3.51%
ROICexcg growth 5Y-1.27%
ROICexc growth 3Y-4.28%
ROICexc growth 5Y-1.4%
OM growth 3Y-5.61%
OM growth 5Y-1.02%
PM growth 3Y-56.68%
PM growth 5Y-34.67%
GM growth 3Y0.24%
GM growth 5Y1.23%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.1 | ||
| Debt/FCF | 12.96 | ||
| Debt/EBITDA | 3.48 | ||
| Cap/Depr | 89.2% | ||
| Cap/Sales | 9.6% | ||
| Interest Coverage | 0.97 | ||
| Cash Conversion | 90.9% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.01 | ||
| Quick Ratio | 2.01 | ||
| Altman-Z | 1.8 |
F-Score5
WACC8.79%
ROIC/WACC0.27
Cap/Depr(3y)97.03%
Cap/Depr(5y)109.5%
Cap/Sales(3y)9.85%
Cap/Sales(5y)9.84%
Profit Quality(3y)1105%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-67.69%
EPS 3Y-1.04%
EPS 5Y16.79%
EPS Q2Q%-600%
EPS Next Y-62.53%
EPS Next 2Y8.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.76%
Revenue growth 3Y11.64%
Revenue growth 5Y9.65%
Sales Q2Q%9.19%
Revenue Next Year7.99%
Revenue Next 2Y8.17%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.09%
EBIT growth 3Y5.38%
EBIT growth 5Y8.53%
EBIT Next Year110.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98.28%
FCF growth 3Y90.52%
FCF growth 5Y8.35%
OCF growth 1Y44.54%
OCF growth 3Y15.95%
OCF growth 5Y17.44%